Ignite Creation Date:
2025-12-26 @ 10:18 PM
Ignite Modification Date:
2026-05-05 @ 5:35 AM
Study NCT ID:
NCT04987112
Status:
RECRUITING
Last Update Posted:
2023-12-22
First Post:
2021-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
Sponsor:
CanWell Pharma Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAN1012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None